A new treatment option for adult ADHD patients was approved by Health Canada in December 2017 and is now available in pharmacies. Foquest® (methylphenidate HCl controlled-release capsules), from Purdue Pharma Canada, is indicated for the treatment of ADHD in adults (≥18 years of age).
Foquest is a once-daily, long-acting methylphenidate controlled-release capsule that has an onset of action within one hour and a 16-hour duration of action. It is available in seven capsule strengths – 25, 35, 45, 55, 70, 85, 100 mg.
Privacy & Cookies Policy
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.